Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Myeloma Drug Works Better at Lower Dose


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
Zapping Vocal Tumors
Keep Away Ovarian Cancer
Breakthrough for Fatal Lung Disease
Preventing Breast Cancer
More...

Related Animations
 border=
Angioplasty
Breast Self-Exam Video
Colon Cancer
Coronary Bypass Surgery
More...

Related Drug Information
 border=
Accupril
Altace
Avapro
Cartia XT
More...

Related News Articles
 border=
You May Be the Key to Cancer Prevention
New Drug Shows Promise in Use With Coronary Stents
Managing Stress Can Lower Heart Death Risk
Anniversary of Parent's Passing Can Trigger Death
More...


Page:  << Prev | 1 | 2 | 3

Streicher stressed that the findings remain preliminary, however.

"We don't know what it will look like at two years," he said. "It's possible that we'll find out that the benefits continue for a long time, or that something else needs to be done somewhere down the line if patients relapse. Those are important questions that still need to be answered."

Lichtenfeld called the trial's success "all part of the targeted therapy story," which he said is revolutionizing cancer care.

Text Continues Below



But he also warned that current funding shortfalls at public health institutions such as the NCI -- which support and organize many of these types of clinical trials -- threaten these types of advances.

"We are understanding myeloma better and we are able to apply these drugs," Lichtenfeld said. "But if we do not continue to support these types of activities, we stand a chance of losing our progress."

More information

There's more on myeloma at the American Cancer Society.

Page:  << Prev | 1 | 2 | 3

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 4/6/2007

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





New Features

New ADHD Site!

SOURCES: Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society, Atlanta; Howard Streicher, M.D., senior investigator, U.S. National Cancer Institute, Bethesda, Md.; April 4, 2007, prepared statement, U.S. National Cancer Institute


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map